Navigation Links
ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
Date:10/29/2008

Net income in the third quarter and nine-months ended September 30, 2008 was $27.1 million and $68.6 million, respectively, compared to a net income of $21.3 million and $75.0 million for the same periods in 2007. Net income per share for the quarter ended September 30, 2008 was $0.39 per share, basic and $0.33 per share, diluted, compared to a net income of $0.30 per share, basic, and $0.26 per share, diluted, for the same period in 2007. Net income per share for the nine-months ended September 30, 2008 was $0.98 per share, basic, and $0.84 per share, diluted, compared to a net income of $1.07 per share, basic, and $0.96 per share, diluted, for the same period in 2007.

The primary drivers of the increase in net income for the third quarter were the increase in net sales and a lower effective tax rate. The decrease in net income for the nine months ended September 30, 2008 were the effects of lower operating income discussed above, partially offset by a lower effective tax rate.

Operating Highlights

During the three and nine months ended September 30, 2008, net sales of Vancocin increased 29.4 percent and 16.8 percent, respectively, compared to the same periods in 2007 primarily due to the impact of a price increase during 2008 and the increase in the number of units sold.

The cost of sales for Vancocin for the three and nine months ended September 30, 2008 increased $0.4 million and decreased $0.1 million, respectively, as compared to the same periods in 2007. For the three and nine month periods ended September 30, 2008 the cost of sales was $2.5 million and $6.8 million, respectively, compared to $2.0 million and $6.9, respectively, for the same period in 2007.

Investment in our product pipeline and the Company continued to grow as research and development (R&D) and selling, general and administrative (SG&A) expenses in the third quarter and nine-months ended September 30, 2008 were $29.1 million and $88.2 million, respec
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
2. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
4. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
5. ViroPharma Provides Update on Vancocin(R)
6. ViroPharma Augments Senior Management
7. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
8. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
9. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. ViroPharma to Present at the Maxim Group First Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend Report ... and statistics on one of the nation’s biggest drivers ... Management will discuss key findings from the report in ... Spend,” a complimentary March 19 webinar, managed and moderated ... makes up more than a quarter of total drug ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
(Date:3/6/2015)... 2015 Dr. Mark Sowell recently returned from ... AZ. Offering programs for advanced education in the field of ... , As a visiting faculty member of this prestigious ... each time he visits Spear Education to participate in a ... “we are training only the top 10% and those willing ...
(Date:3/5/2015)... From Oct. 5-10, Mumbai, India will serve as ... These dates include the following activities:, ... October 6: Conference Day 1, ending with a Fashion ... 2, ending with Local Entertainment and Dinner , ... Materials Meetings , October 9-10: Textiles in India ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict ... plaintiff Coleen M. Perry a total of $5.7 million for ... mesh sling device, manufactured by Ethicon, Inc., a subsidiary of ... at Wagstaff & Cartmell in Kansas City, Mo., ... Rich Freese and Tim Goss of Freese & Goss ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2
... AND PENN,S WHARTON IN FULD & COMPANY WAR ... Time in Last Five YearsCAMBRIDGE, Mass., April 13 ... predicted in a public war game that most ... healthcare delivery industries--including Microsoft, McKesson, Kaiser-Permanente, and Allscripts--will ...
... Misonix, Inc. (Nasdaq: MSON ), a ... in Europe is used for the ablation of tumors ... into a new, three year, exclusive distribution agreement with ... in Barcarena, Portugal, for the distribution of the SonaStar(TM) ...
... N.J., April 13 Medco Health Solutions, Inc. (NYSE: ... results in a press release before the market opens on ... hold a conference call to review the financial results, outlook ... access the live conference call via telephone: , Dial ...
... William Pursley, has agreed to become Chairman of Rx for ... For 25 years Mr. Pursley has held major executive positions ... and was on the marketing team that launched Human Growth ... huge success. In 1985 Pursley joined Genzyme Corp as VP ...
... DENVER, April 13 Scotland has announced that it ... Nicola Sturgeon announced the pilot program during a visit ... Friday, April 10, where she met with nurses, clients ... is a voluntary prevention program providing nurse home visitation ...
... Line of Customizable Fitness, Nutrition and Wellness Products Specifically ... scope as the leading global specialty retailer of nutritional ... of women,s products called GNC WELLbeING ... one-source line of whole body health products created exclusively ...
Cached Medicine News:Health News:Rivals Will Drive Toward Alliances or Merge in Healthcare I.T. Industry, National Biz School War Game Predicts 2Health News:Rivals Will Drive Toward Alliances or Merge in Healthcare I.T. Industry, National Biz School War Game Predicts 3Health News:Rivals Will Drive Toward Alliances or Merge in Healthcare I.T. Industry, National Biz School War Game Predicts 4Health News:Misonix Announces New Distribution Agreement for Portugal 2Health News:Misonix Announces New Distribution Agreement for Portugal 3Health News:Medco Announces Date for First-Quarter 2009 Financial Results 2Health News:Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc. 2Health News:Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc. 3Health News:Scotland Announces Establishment of Nurse-Family Partnership Program 2Health News:GNC Launches the First-Ever Comprehensive Line of Whole Body Health Products Exclusively for Fit and Active Women 2Health News:GNC Launches the First-Ever Comprehensive Line of Whole Body Health Products Exclusively for Fit and Active Women 3
(Date:3/5/2015)... , March 5, 2015 BioLineRx ... clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and ... has commenced an underwritten public offering of American ... its Ordinary Shares. All of the ADSs in ... JMP Securities is acting as ...
(Date:3/5/2015)... Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... and year ended January 3, 2015.  , Revenues ... record for the Company and up 11% from $10.6 million ... million, also a record, up 12% from $38.3 million in ... was 50.1%, up from 48.6% in the fourth quarter of ...
(Date:3/5/2015)... -- BioPhotas, Inc., an FDA registered medical device manufacturer selling ... treat skin, muscle and joint conditions, today announced that ... provide BioPhotas, flagship product, the Celluma, to ... Commenting on the alliance, Patrick Johnson ... at the Warrior Hope and Care Center had suffered ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3
... CardioFocus, Inc., developer of the Endoscopic Ablation ... (AF), convened international leaders in electrophysiology to discuss ... catheter ablation for the treatment of paroxysmal AF. ... German Society for Cardiology Annual Meeting in Mannheim, ...
... SAN DIEGO, April 27, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... and Chief Executive Officer of Neurocrine Biosciences, will be presenting ...   The live presentation takes place on ... 7:40 a.m. Pacific Time.  The presentation will be webcast and ...
Cached Medicine Technology:International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter 2International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: